脊髓电刺激与靶向药物输注治疗慢性疼痛的选择:结局预测公式
该回顾性队列研究纳入1994至2013年Cleveland Clinic疼痛科945例接受脊髓电刺激(SCS)试验的慢性非恶性疼痛患者,其中119例(12.6%)在SCS失败后经靶向药物输注(TDD)获得充分镇痛。研究识别出性别、年龄、抑郁和原发疼痛诊断与结局显著相关,并构建了预测SCS成功的公式,提示老年男性脊柱源性疼痛患者可能更宜优先考虑TDD。
要点
- SCS试验失败后,12.6%的患者经TDD获得充分镇痛。
- 男性SCS镇痛成功的可能性比女性低52%。
- 年龄每增加1岁,SCS成功几率下降6%。
核心结论
- 老年男性脊柱源性疼痛患者比SCS更可能从TDD获益。
- 该亚组或可提前考虑TDD而非等待SCS失败,可能更高效且具成本效益。
- 这些回顾性发现需前瞻性对照研究验证所推导的预测公式。
研究设计与样本
- 经机构审查委员会批准,提取Cleveland Clinic疼痛科1994至2013年接受SCS试验患者的电子病历数据。
- 样本分为SCS成功组与SCS失败后转TDD组,共945例。
- 进行单因素和多因素分析,并创建成功结局的预测公式。
主要发现
- 945例中119例(12.6%)在SCS失败后经TDD获得充分镇痛。
- 该亚组中性别、年龄、抑郁和原发疼痛诊断存在显著差异。
- 男性SCS镇痛成功的可能性低52%。
- 年龄每增加1岁,SCS成功几率下降6%。
- 合并抑郁者SCS成功可能性高63%。
关键数值与推荐
- 基于逻辑回归模型创建预测SCS成功的公式。
- 老年男性脊柱源性疼痛患者更可能从TDD而非SCS获益。
临床怎么用
- 对老年男性脊柱源性疼痛患者,可考虑提前评估TDD而非等待SCS失败。
- 性别、年龄、抑郁和疼痛诊断可用于SCS与TDD的选择参考。
- 预测公式需前瞻性验证后方可用于临床决策。
局限性
- 回顾性研究设计。
- 预测公式为推导所得,尚需前瞻性对照研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Contemporary nonmalignant pain treatment algorithms commence with conservative non-invasive strategies, later progressing from minimally invasive interventions to invasive techniques or implantable devices. The most commonly used implantable devices are spinal cord stimulation (SCS) systems or targeted drug delivery (TDD) devices. Historically, SCS had been considered in advance of TDD, positioning TDD behind SCS failures. Following Institutional Review Board approval, data were extracted from electronic medical records of patients who underwent SCS trial in the Department of Pain Management at Cleveland Clinic from 1994 to 2013. The sample size was analyzed in two cohorts: those who succeeded with SCS and those who failed SCS and consequently proceeded to TDD. Univariate and multivariate analyses were performed and a predictive formula for successful outcomes was created. 945 patients were included in the cohort of which 119 (12.6%) subjects achieved adequate pain relief with TDD after failure of SCS. Gender, age, depression and primary pain diagnosis were significantly different in this subgroup. Males were 52% less likely to experience pain relief with SCS. The odds of SCS success decreased as age increased by 6% per year. Patients with comorbid depression, interestingly, were 63% more likely to succeed with SCS. A logistic model was created to predict SCS success which was used to create a predictive formula. Older male patients diagnosed with spine-related pain were more likely to benefit from TDD than SCS. This observation potentially identifies a subgroup in whom consideration for TDD in advance of SCS failure could prove more efficient and cost effective. These retrospective findings warrant prospective comparative studies to validate this derived predictive formula.
引用
- Mekhail N, Mehanny DS, Armanyous S, et al. Choice of spinal cord stimulation versus targeted drug delivery in the management of chronic pain: a predictive formula for outcomes. Reg Anesth Pain Med. 2020. PMID: 31932490. doi:10.1136/rapm-2019-100859
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。